PCI BIotech: Disclosure of voting rights for Chair of the Board

Company Overview - PCI Biotech Holding ASA is preparing for its annual general meeting scheduled for 22 May 2025, which will be opened by Hans Peter Bøhn, the Chair of the Board of Directors [2]. Shareholder Information - Hans Peter Bøhn holds 123,662 shares, which accounts for 0.3 percent of PCI Biotech's share capital. Additionally, he has received powers of attorney to represent and vote for 3,957,330 shares, bringing his total voting representation to 10.9 percent of the share capital [2]. Powers of Attorney - A significant portion of the powers of attorney held by Mr. Bøhn are without voting instructions, and these powers are only valid for the annual general meeting on 22 May 2025 [2].